sacituzumab govitecan,lutetium-177 psma-i&t,radium-223
novartis,gilead sciences,bayer
['crpc', 'alphabet', ' sg ', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
#alphabet: a phase i/ii trial evaluating the combination of radium-223 and [177lu]lu-psma-i&amp;t in patients with #mcrpc. presentation by . #gu23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology